Offner Damien, Wagner Quentin, Idoux-Gillet Ysia, Gegout Hervé, Ferrandon Arielle, Schwinté Pascale, Musset Anne-Marie, Benkirane-Jessel Nadia, Keller Laetitia
INSERM (French National Institute of Health and Medical Research), 'Osteoarticular and Dental Regenerative Nanomedicine' Laboratory, UMR 1109, Faculté de Médecine, F-67085 Strasbourg cedex, FMTS, France.
Université de Strasbourg, Faculté de Chirurgie Dentaire, 8 rue Sainte Elisabeth, F-67000 Strasbourg, France.
Biomed Mater Eng. 2017;28(s1):S185-S192. doi: 10.3233/BME-171640.
The time needed to obtain functional regenerated bone tissue depends on the existence of a reliable vascular support. Current techniques used in clinic, for example after tooth extraction, do not allow regaining or preserving the same bone volume. Our aim is to develop a cellularized active implant of the third generation, equipped with human mesenchymal stem cells to improve the quality of implant vascularization. We seeded a commercialized collagen implant with human mesenchymal stem cells (hMSCs) and then with human umbilical vein endothelial cells (HUVECs). We analyzed the biocompatibility and the behavior of endothelial cells with this implant. We observed a biocompatibility of the active implant, and a re-organization of endothelial cells into clustered networks. This work shows the possibility to develop an implant of the third generation supporting vascularization, improving the medical care of patients.
获得功能性再生骨组织所需的时间取决于可靠的血管支持的存在。目前临床使用的技术,例如拔牙后,无法恢复或保留相同的骨体积。我们的目标是开发第三代细胞化活性植入物,配备人间充质干细胞以提高植入物血管化的质量。我们将人间充质干细胞(hMSCs)接种到商业化的胶原植入物上,然后接种人脐静脉内皮细胞(HUVECs)。我们分析了这种植入物的生物相容性以及内皮细胞的行为。我们观察到活性植入物具有生物相容性,并且内皮细胞重新组织成簇状网络。这项工作表明开发支持血管化的第三代植入物以改善患者医疗护理的可能性。